<DOC>
	<DOCNO>NCT00347490</DOCNO>
	<brief_summary>Primary objective : To assess clinical efficacy single bolus anticoagulation Enoxaparin chronic hemodialysis Secondary objective : To assess safety tolerability number spontaneously report adverse event patient</brief_summary>
	<brief_title>HENOX : Enoxaparine Hemodialysis</brief_title>
	<detailed_description />
	<criteria>End stage renal failure require maintenance hemodialysis least twice week Has arteriovenous fistula arteriovenous graft upper extremity apply blood flow &gt; = 250ml/min vascular access hemodialysis . Stable hemodialysis prescription least 1 month enrollment UFH ( Unfractionated Heparin ) prescribe anticoagulant previous hemodialysis prescription No sign active infection . Absence recent cardiovascular complication myocardial infarction , DVT ( Deep Venous Thrombosis ) , arterial occlusion , pulmonary embolism , cerebrovascular disease previous 3 month . Women breastfeed , pregnant childbearing age use medically acceptable effective contraception Patients evidence active bleeding disorder Contraindication anticoagulation : Prior history cerebral hemorrhage time Coagulopathy ( acquire inherit ) Recent surgery Major surgery neurosurgery within past 3 month Minor surgery intraocular surgery within 1 month . Uncontrolled predialytic arterial hypertension ( systolic BP &gt; 200 mmHg diastolic BP &gt; 110 mmHg ) 2 successive reading Impaired hemostasis i.e. , know suspect coagulopathy ( acquire inherit ) : baseline platelet count &lt; 100,000/mm3 patient without baseline diagnosis active cancer undergo chemotherapy treatment ( patient diagnosis cancer undergo chemotherapy , baseline platelet count &gt; 70,000/mm3 ) ; aPTT ( activate Partial Thromboplastin Time ) 1.5X laboratory upper limit normal ; international normalize ratio ( INR ) &gt; 1.5 Indication thrombolytic therapy ischemic heart disease , ischemic stroke . Need curative treatment anticoagulant therapy ( DVT , pulmonary embolism , ischemic heart disease ) Patients treated oral anticoagulant therapy within 72 hour prior inclusion Patients spinal epidural analgesia lumbar puncture within precede 24 hour Abnormal liver enzyme total bilirubin within 2 week ( SGPT , SGOT , total bilirubin 2 time Upper normal limit ) Known hypersensitivity heparin LMWH ( Low Molecular Weight Heparin ) , pork derive product History document episode heparin LMWH induce thrombocytopenia and/or thrombosis . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>